Malaria, control and diagnosis

Iranian Red Crescent Medical Journal

Volumn 12, Issue 3, 2010, Pages 239-241

  Hatam, G R ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Epidemic features; Iran; Malaria; Plasmodium; Serology

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ; CHLOROQUINE;

AGE DISTRIBUTION; ARTICLE; DIAGNOSTIC ACCURACY; DISEASE TRANSMISSION; DRUG EFFICACY; FLUORESCENT ANTIBODY TECHNIQUE; GEOGRAPHIC DISTRIBUTION; HEALTH PROGRAM; HUMAN; INCIDENCE; INFECTION RATE; INTERMETHOD COMPARISON; MALARIA; MALARIA CONTROL; MALARIA FALCIPARUM; MICROSCOPY; PARASITE EXAMINATION; PLASMODIUM VIVAX MALARIA; POLYMERASE CHAIN REACTION; SEX DIFFERENCE;

EID: 77953284077     PISSN: 20741804     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Nwaka S. Drug discovery and beyond: the role of public-private partnerships in improving access to new malaria medicines. Trans R Soc Trop Med Hyg 2005; 99S:S20-S29 [16085175]
2. Sadrizadeh B. Malaria in the world, in the eastern Mediterranean region and in Iran: Review article. WHO/ EMRO Report, 2001; p.1-13.
3. Kain KC, Harrington MA, Tennyson S, Keystone JS. Imported malaria: prospective analysis of problems in diagnosis and management. Clin Infect Dis 1998;27:142-9. [9675468] [doi:10.1086/514616]
4. Gosling RD, Drakeley CJ, Chandramohan D. Effective malaria control: better burden estimates needed. Lancet 2008;371:724. [18 313500] [doi:10.1016/S0140-6736(08)60338-4]
5. Edrissian GhH. Malaria in Iran: Past and Present Situation. Iranian J Parasitol 2006;1:1-14.
6. Malaria Eradication Organization and Communicable Diseases Control. Report of the Planning Group of Malaria Eradication on activities of malaria eradication in health services in Iran and planning for the future operational programme; 1980.
7. World Health Organization. Current global malaria situation. WHO Expert Committee on Malaria. Tech Rep Series, 2000;812:3-6.
8. Edrissian GhH, Nateghpour M, Afshar A, Mohsseni Gh. Monitoring the response of Plasmodium falciparum and Plasmodium vivax to antimalarial drugs in the malarious areas in south-east Iran. Arch Irn Med 1999;2:61-6.
9. Greenwood BM. Control to elimination: implications for malaria research. Trends Parasitol 2008; 24:449-54. [18760671] [doi:10.1016/ j.pt.2008.07.002]
10. Feachem R, Sabot O. A new global malaria eradication strategy. Lancet 2008;371:1633-5. [18374409] [doi: 10.1016/S0140-6736(08)60424-9]
11. Abeku TA, Hay SI, Ochola S, Langi P, Beard B, de Vlas SJ, Cox J. Malaria epidemic early warning and detection in African highlands. Trends Parasitol 2004;20:400-5. [15324728] [doi:10.1016/j.pt.2004.07.005]
12. Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005;434:214-7. [15759000] [doi:10. 1038/nature03342]
13. Lalloo DG, Shingadia D, Pasvol G, Chiodini PL, Whitty CJ, Beeching NJ, Hill DR, Warrell DA, Bannister BA; HPA Advisory Committee on Malaria Prevention in UK Travellers. UK malaria treatment guidelines. J Infect 2007;54:111-21. [17215045] [doi:10.1016/j.jinf.2006.12.003]
14. Ebrahimzadeh A, Fouladi B, Fazaeli A. High rate of detection of mixed infections of Plasmodium vivax and Plasmodium falciparum in South- East of Iran, using nested PCR. Parasitol Int 2007;56:61-4. [1725789 1] [doi:10.1016/j.parint.2006.12.001]